VereFever™ Lab-On-Chip for the Simultaneous Detection of Tropical Infectious Diseases including Dengue, Zika, Malaria and Chikungunya,

VereFever™ is able to detect, differentiate and identify 7 different major tropical diseases from a single blood sample, including Malaria, Dengue, Chikungunya, West Nile, Yellow Fever, Japanese Encephalitis and Zika by using the STMicroelectronics proprietary Lab-on-Chip platform that integrates two powerful molecular biological applications, Polymerase Chain Reaction (PCR) and a microarray.

More information

AVA and Veredus Laboratories announces the launch of World’s First Poultry Biochip “VereVet”

The Agri-Food and Veterinary Authority of Singapore (AVA) and Veredus Laboratories has jointly launched VereVet™, a portable Lab-on-Chip application that is able to detect, differentiate and identify nine major poultry infectious disease agents from one sample in one single test.

More information

Veredus Laboratories’ VerePLEX™ Biosystem Deployed at FIFA World Cup 2014 for Biosurveillance.

VerePLEX™ Biosystem has been selected by the Brazilian civil security forces as a system to monitor and identify potential biological threats during the  FIFA World Cup 2014.

More information

Veredus Announces VereMERS™ for detection of MERS-CoV.

Veredus has successfully developed VereMERS™, a Lab-on-Chip application that is able to detect, from a sequence perspective, Middle East Respiratory Syndrome Coronavirus (MERS-CoV).

More information

A*STAR and Veredus Laboratories Create Market’s First Lab-on-Chip for the Detection of Multiple Tropical Infectious Diseases.

The Agency for Science, Technology and Research (A*STAR) and VeredusLaboratories announced the launch of VereTrop™, the first biochip in the molecular diagnostics market that can identify 13 different major tropical diseases, from a single blood sample.

More information

Veredus Laboratories Confirms that the VereFlu™ Lab-on-Chip Detects the Current Subtype of Avian Flu H7N9 in Addition to All Other Human Flu Subtypes

The current version of VereFlu detects the current subtype of H7N9 (Avian Flu) that is responsible for the Flu outbreak in China. H7N9 is the latest mutation to cause concern and increased surveillance in the region.

More information

Veredus Laboratories Launches Powerful Multiplexed Molecular Diagnostic Lab-on-Chip Targeting Global Threat of Multi-Drug-Resistant Tuberculosis

VereMTB™, a multiplexed molecular diagnostic chip capable of fast and accurate detection of Mycobacterium Tuberculosis Complex (MTBC) and MDR-TB, as well as 9 other clinically relevant non-tubercular mycobacterium.

More information

Veredus Laboratories develops Lab-on-Chip solution to detect and differentiate several food-borne pathogens, including Escherichia coli (E. coli)

June 23, 2011

VereFoodborne™, a Lab-on-Chip application that is able to detect 10 to 12 food-borne pathogens in one test, was launched today.

More information

Veredus Laboratories’ VereFlu™ Chip Tested Successfully on Clinical Samples of Pandemic H1N1-2009 Influenza Strain

July 6, 2009

The VereFlu™ chip, based on STMicroelectronics’s lab-on-chip platform, is a portable lab-on-chip application that can identify and differentiate human strains of Influenza A and B viruses in a single test with high accuracy and sensitivity. VereFlu™ chip has been tested successfully on confirmed pandemic H1N1-2009 influenza positive samples in a joint trial with the National Public Health Laboratory (NPHL).

More information

Veredus Laboratories Updates VereFlu™ Lab-on-Chip to Specifically Detect the Current Strain of Swine Flu H1N1 in Addition to All Other Human Flu Strains

April 29, 2009

Veredus Laboratories today announced that the current version of VereFlu™ is able to detect, from a sequence perspective, the variant strain of H1N1 (swine flu) that is responsible for the Flu outbreak in Mexico.

More information